CIK 0002093101
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Atrium Therapeutics, Inc.
Sign in to watch- Ticker
- RNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 394639499
- Phone
- +1 619-876-0700
- Business address
- 10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-18 | Gallagher Kathleen P. | Shares withheld for taxes | −11,632 | $8.95 | $104K | 119,729 |
| 2026-04-20 | Gallagher Kathleen P. | Grant or award | +102,500 | 131,361 | ||
| 2026-04-20 | Gallagher Kathleen P. | Grant or award · Stock Option (Right to Buy) | +205,000 | 205,000 |
Page 1 of 1 · 3 trades